Structure based virtual screening and molecular simulation study of FDA-approved drugs to inhibit human HDAC6 and VISTA as dual cancer immunotherapy
基于结构的虚拟筛选和分子模拟研究FDA批准的抑制人HDAC6和VISTA的药物作为双重癌症免疫疗法
期刊:Scientific Reports
影响因子:3.9
doi:10.1038/s41598-023-41325-9
Shahab, Muhammad; Al-Madhagi, Haitham; Zheng, Guojun; Zeb, Amir; Alasmari, Abdullah Fayez; Alharbi, Metab; Alasmari, Fawaz; Khan, Muhammad Qayash; Khan, Momin; Wadood, Abdul
